A double-blind, randomized study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple ABT-436 doses in healthy adults.
Phase of Trial: Phase I
Latest Information Update: 18 Oct 2016
At a glance
- Drugs ABT 436 (Primary)
- Indications Anxiety disorders; Depression
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 18 Oct 2016 New trial record